Cambridge, United Kingdom

David J Cavalla

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 259(Granted Patents)


Location History:

  • London, GB (1989 - 1992)
  • Cambridge, GB (1991 - 2016)
  • Cambridgeshire, GB (2017)

Company Filing History:


Years Active: 1989-2017

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):Explore Patents

Title: David J. Cavalla: Innovator in Respiratory and CNS Disorder Treatments

Introduction: David J. Cavalla, a prominent inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceuticals through his innovative developments. With a remarkable portfolio consisting of 43 patents, his work focuses primarily on treatments related to respiratory depression and central nervous system (CNS) disorders.

Latest Patents: Among his latest patents, Cavalla has developed compounds that are specifically designed for the treatment of respiratory depression. One such patent involves the creation of tricyclic dibenzothiazepine compounds. Additionally, he has patented dibenzothiazepine derivatives that serve a crucial role in treating CNS disorders. These compounds are defined in technical terms, indicating their complex molecular structures and the potential they hold for therapeutic applications.

Career Highlights: Throughout his career, Cavalla has worked with reputable organizations in the pharmaceutical industry. Notably, he has been associated with Euro-Celtique S.A. and Glaxo Group Limited, where he has honed his expertise and made advancements in drug development. His prolific output in patenting innovative drugs underscores his dedication and impact on the industry.

Collaborations: Collaboration has been an integral part of Cavalla's journey. He has worked alongside talented professionals such as Mark Chasin and Peter Hofer, contributing to the collective pursuit of breakthroughs in medical treatments. These collaborations have likely fostered an environment of shared knowledge and creativity that is essential in the fast-paced world of pharmaceutical innovations.

Conclusion: David J. Cavalla stands out as a significant figure in the realm of pharmaceutical innovations. His extensive patent portfolio reflects his commitment to addressing critical health challenges, particularly in respiratory and CNS disorders. With a career marked by collaboration and a focus on groundbreaking treatments, Cavalla's work continues to inspire future innovations in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…